Clinical trial NCT04754893: Postbariatric EArly Discharge Controlled by Healthdot
Official title: Postbariatric EArly Discharge Controlled by Healthdot (PEACH)
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Bariatric Surgery Candidate
Lead sponsor: Philips Electronics Nederland B.V. acting through Philips CTO organization
Sponsor class: INDUSTRY
First posted: 2021-02-15
Enrollment: 208
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: OTHER

Brief summary: This clinical investigation is a single center patient preference trial in a tertiary hospital in the Netherlands, designed to compare the outcome of two different recovery paths after standard of care bariatric surgery. The difference between both recovery paths is that half of the patients will get the standard of care by staying one night in the hospital before returning home (group B), while the other half will receive a Healthdot directly after surgery and leave the hospital on the same day (evening) (group A). 200 patients will be recruited and can choose whether they want to be assigned to the the regular recovery path or receive a Healthdot and leave the hospital on the same day. If they have no preference they will be randomly assigned to one of the two groups. Patients in the outpatient recovery group will wear the Healthdot for 7 days at home and vital signs (heart rate and respiratory rate, together with context data on activity and posture) will be transmitted to the hospital to monitor recovery. The study is mainly designed to investigate if the clinical outcome in both groups is equal (non-inferiority) based on a combined outcome measures like 30 days readmission rate and patient satisfaction.


Eligibility criteria: Inclusion Criteria:

* Adult (equal or above 18)
* Approval for primary bariatric surgery (gastric sleeve or bypass) by a multidisciplinary bariatric team
* Willing and able to sign informed consent form
* Able to understand instructions
* In possession of a telephone on which patient can be reached for the duration of participation (day 1-8)
* An adult person must be present at the same location as the patient during the first night following surgery who is able to mobilize help or seek medical care if necessary.

Exclusion Criteria:

* Patients of psychiatric wards, inmates of prisons, or other state institutions
* Investigator or any other team member involved directly or indirectly in the conduct of the clinical study
* Any skin condition, for example prior rash, discoloration, scars or open wounds at the area (Left lower rib) where the Healthdot needs to be placed
* Known allergy for the tissue adhesive used in the Healthdot (white band-aid)
* Use of topical that is known to influence the skin at the test area (such as medical and non-medical creams or lotions)
* Patient with active implantables such as Implantable Cardioverter Defibrilator (ICD) and pacemaker
* Expected participation less than 8 days
* Left lower rib (place where Healthdot will be applied) is involved in the area of surgery, area of disinfection or area where bandages are needed.
* Patients with antibiotic resitant infections (e.g. MRSA)

Primary outcomes:
measure: Mortality
timeFrame: Within 30 days after primary surgery
measure: Severe postoperative complications (Clavien-Dindo IIIb or higher)
timeFrame: Within 30 days after primary surgery
measure: Readmission (at least one night in hospital)
timeFrame: Within 30 days after primary surgery
measure: Mild complications (Clavien-Dindo II and IIIa)
timeFrame: Within 30 days after primary surgery
measure: Prolonged length of stay (3 days or more in hospital)
timeFrame: Within 30 days after primary surgery
Secondary outcomes:
Other outcomes:
Locations:
city: Eindhoven
country: Netherlands
facility: Catharina Hospital
state: Noord-Brabant
Study officials:
affiliation: Catharina Hospital, Eindhoven, The Netherlands
name: Simon Nienhuijs
role: PRINCIPAL_INVESTIGATOR
References:
citation: Scheerhoorn J, van Ede L, Luyer MDP, Buise MP, Bouwman RA, Nienhuijs SW. Postbariatric EArly discharge Controlled by Healthdot (PEACH) trial: study protocol for a preference-based randomized trial. Trials. 2022 Jan 21;23(1):67. doi: 10.1186/s13063-022-06001-9.